Supplemental Figure 1 from The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

Authors :: Celina M. D'Cruz
Edwin A. Clark
Stephen E. Fawell
Corinne Reimer
Michael Zinda
Ammar Adam
Delphine Nicolle
Olivier Déas
Stefano Cairo
Joanne Wilson
Aaron Smith
Maureen Hattersley
David Linsenmayer
Garry Beran
Melanie M. Frigault
Ryan E. Henry
Rhys D.O. Jones
Evan R. Barry
Alwin G. Schuller
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure 1. In vitro activity of AZD6094, sunitinib, crizotinib, SGX-523, JNJ3887605, PHA-665752, and INC280 in AGS and GTL16 gastric cancer cells

Full Text Access

Tools